Company profile
LifePoint, Inc.
OTC: LFPI · Healthcare · Medical - Instruments & Supplies
#1417 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ —GM —SS 54
v0.1 · 5/100 weight · pillars only
↑ listing tenure, balance-sheet leverage · ↓ revenue growth (YoY), return on equity
Methodology →Revenue TTM
$81.9k
Rev growth YoY (TTM)
-161.6%
Net income (FY)
-$15.2M
Employees
52
as of 2026-08-29
Market cap
$31.3k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue-$18.5k-$18.5k2003
Net income-$15.2M-$15.2M2003
Operating income-$7.5M-$7.5M2003
Total assets$8.8M$8.8M2003
Liabilities$2.5M$2.5M2003
Equity$6.4M$6.4M2003
Revenue trend
FY1998 – FY2003 · USD
FY98
FY99
FY00
FY01
FY02
FY03
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is LifePoint, Inc.’s revenue?
LifePoint, Inc. booked -$18.5k in FY2003 revenue, contracting 138% year over year — among the slowest-growing Healthcare companies we track, at a 82333.0% net margin.
Peers · Healthcare
Attovia Therapeutics, Inc.——BlossomHill Therapeutics, Inc.——Vogenx Inc.——Plant-Based Investment Corp.——Neighbors
San Bernardino →Key facts
CEORichard Wadley
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersOntario, CA
ExchangeOTC: LFPI
Employees52
IPO date1994-11-01
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.